Additionally, Akt activity has also been shown to be upregulated in type II alveolar epithelial cells (AEC2) of patients with IPF, and inhibition of enzymatic activity in these cells has proven to be effective in reducing tissue remodeling to bleomycin in the mouse lung [21]. This evidence concerns the gene AKT1 and idiopathic pulmonary fibrosis.